Sightline samples

Sightline Assessment · Missouri Cancer Associates · illustrative

Bounded assessment — competing hypotheses

This sample shows what happens when the evidence supports more than one explanation. It does not force a single story. An assessment is the best read given current evidence — not final truth.

Reconstructed from a real portfolio engagement for teaching purposes. Not a live client file. No analytics reproduced; qualitative artifact review only.

01 — Observations

What we saw before naming a cause

Observations describe artifacts and behavior — not why they happened.

  • Hoot Design Co. delivered a sophisticated new brand identity — guidelines, print, and strategic intent documented
  • The existing web presence did not yet express that identity at the same level of care as the print system
  • Typography, color, and tone on key patient paths read closer to a generic healthcare template than to the new brand system
  • Multiple parties touched the project: brand agency, web implementation, internal stakeholders — no single owner of the brand-to-web seam
  • Leadership believed the rebrand was "done" because guidelines existed; patients experienced the website separately

02 — Hypotheses

Competing explanations for the same seam

Each hypothesis names where meaning might be degrading and what we'd expect to see if it were true.

Signal Loss

H1 — Strategy → web handoff

Interpretation authority shifted from brand strategy to web implementation without preserving rationale — so developers and content editors made local choices that drifted from intent.

If true, we'd expect: Specific brand rules missing or simplified in CSS/content; no documented translation spec; decisions in the build that contradict guidelines with no recorded rejection.

Trust Compression

H2 — Brand weight not carried digitally

The institution had matured clinically; the brand was designed to carry that legitimacy — but digital execution never inherited the same institutional weight, so patients still read "regional" instead of "specialized."

If true, we'd expect: Visual tone underselling clinical depth; photography and hierarchy that feel safer/generic; gap between print collateral impact and homepage first impression.

Complexity Drag

H3 — Ownership fragmentation

Too many stakeholders and no source of truth for digital brand — so the site accumulated conflicting priorities faster than it could absorb the new identity.

If true, we'd expect: Inconsistent patterns page-to-page; partial updates; long decision cycles; brand applied in some sections but not others with no documented phasing plan.

BDR-0029

03 — Evidence

What supports or undermines each hypothesis

Evidence is listed per hypothesis — not merged into one narrative.

Hypothesis Supports Undermines
H1 Signal Loss Brand-to-web seam had no named owner; guideline details not operationalized in component-level specs; local web choices visible on patient paths Some brand elements translated faithfully — problem is not total absence of intent
H2 Trust Compression Digital first impression lagged print and clinical reality; tone read cautious/generic where brand aimed for specialized authority Clinical content depth existed — issue is framing and carry, not missing information
H3 Complexity Drag Partial pattern application; multiple vendors and internal teams in chain Drift pattern maps cleanly to a single seam (brand → web), not scattered entropy across every surface

04 — Counterfactuals

Similar seams, different causes

The same observed drift could be produced by more than one failure mode. That is why we hold hypotheses in parallel.

  • Vendor turnover could produce H1-like drift without any strategy gap — new devs inherit CSS, not rationale
  • Budget phasing could produce H3-like partial application without organizational chaos — a planned rollout mistaken for failure
  • Regulatory caution could produce H2-like generic tone deliberately — risk-averse stakeholders choosing "safe" over "distinct"

05 — Assessment (bounded)

Best explanation given current evidence

Assessment ≠ truth. Each hypothesis is scored independently. We do not pick a winner when evidence does not justify it.

Hypothesis Status Note
H1 Signal Loss Partially confirmed Strongest fit for the brand → web seam; handoff and translation gaps evidenced
H2 Trust Compression Partially confirmed Patient-facing weight gap is real; overlaps with H1 — not mutually exclusive
H3 Complexity Drag Refuted as primary Fragmentation present but pattern centers one seam — not system-wide entropy

06 — Exposure surface

Where promises are at risk

Sorted by urgency — may map to more than one hypothesis.

Tier Finding Hypotheses touched
Urgent Brand-to-web seam has no named owner or translation artifact H1, H2
Watch Patient first impression undersells clinical specialization H2
Watch Guidelines treated as deliverable completion, not living system H1, H3
Stable Brand strategy and print system — strong foundation to build from

07 — Intervention

What we built — without collapsing the assessment

Build addresses exposure; it does not prove one hypothesis was "the" cause.

Translated Hoot's brand vision into a high-performance, patient-first web presence — component-level fidelity to guidelines, clear action paths, and digital tone aligned with clinical depth. That work reduces H1 and H2 exposure whether the primary failure was handoff or institutional carry.

A convergent "verdict-only" read would say Signal Loss. This assessment deliberately stays wider.

BDR-0025 · BDR-0029